Inpharma Weekly

, Volume 1649, Issue 1, pp 21–21 | Cite as

Alprostadil [NexMed] received a non-approvable letter from the US FDA

Media release
  • 4 Downloads

Keywords

Transgenic Mouse Erectile Dysfunction Medium Release Alprostadil Carcinogenicity Study 

Copyright information

© Adis International Ltd 2008

Personalised recommendations